State Street SPDR S&P Biotech ETF (NY:XBI)Price and VolumeDetailed Quote
Top NewsMore NewsPerformance
52-Week Range
15.2% below 52-week high
144.12
113.4752W Low
169.8952W High
1 Week
4.8% below 1-week high
143.241W Low
151.341W High
State Street SPDR S&P Biotech ETF (XBI) traded between $113.47 and $169.89 over the past 52 weeks and last traded at $144.12, 15.2% below its 52-week high. Over the past week it ranged between $143.24 and $151.34.
Past 12 Months
-4.3%
-6.0%
-11.8%
+8.5%
+18.6%
+25.9%
1W
-$6.43
1M
-$9.12
3M
-$19.26
6M
+$11.34
YTD
+$22.60
1Y
+$29.62
XBI was +25.9% over the past year, +8.5% over six months, +18.6% year to date, -4.3% in the last week.
12 Months vs Market
XBI
DIA
SPY
QQQ
IWM
Over the past 12 months XBI returned +25.9% versus DIA (Dow) +6.3%, SPY (S&P 500) +8.0%, QQQ (Nasdaq 100) +7.5% and IWM (Russell 2000) +13.2%.
Volume & Liquidity
1.44× 3-mo avg
Today 13,231,107
3-mo avg 9.2M
1W
1M
3M
6M
YTD
1Y
XBI most recently traded 13,231,107 shares against a 3-month average daily volume of 9.2M. More NewsRead MoreVia The Motley Fool
Topics
ETFs
Better Healthcare ETF: Fidelity's Broad, Low-Cost FHLC vs. State Street's XBI Targeting Biotech ↗
October 05, 2026
Via The Motley Fool
Topics
ETFs
Better State Street Healthcare ETF: XBI's Biotech Focus vs. XPH Targeting Pharmaceuticals ↗
October 04, 2026
Via The Motley Fool
Topics
ETFs
VHT vs. XBI: Is Diversified Healthcare Exposure or Biotech Stocks the Smarter Choice for Investors? ↗
September 22, 2026
Via The Motley Fool
Topics
ETFs
Breakfast News: A Conversation With Ionis CEO ↗
August 22, 2026
Via The Motley Fool
IHE vs. XBI: Pharma Stability or Biotech Growth -- Which Healthcare ETF Is the Better Buy? ↗
August 20, 2026
Via The Motley Fool
Topics
ETFs
XBI vs. FBT: Broad Biotech Exposure or Concentrated Bets? ↗
August 19, 2026
Via The Motley Fool
Topics
ETFs
Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI? ↗
August 18, 2026
Via The Motley Fool
Topics
ETFs
Which Is the Better State Street Healthcare ETF: The Broad XLV or the Biotech XBI? ↗
August 03, 2026
Via The Motley Fool
Topics
ETFs
Via The Motley Fool
Topics
ETFs
The Best Biotech Stocks to Buy in 2026 ↗
June 17, 2026
Via The Motley Fool
Topics
ETFs
3 Longevity ETFs to Buy and Hold (and Hold) ↗
June 08, 2026
Via MarketBeat
Via The Motley Fool
Topics
ETFs
Via The Motley Fool
Topics
ETFs
2 Ways to Play the Big Pharma Patent Cliff ↗
May 15, 2026
Via MarketBeat
Via MarketMinute
Via Finterra
Frequently Asked QuestionsIs State Street SPDR S&P Biotech ETF publicly traded?
Yes, State Street SPDR S&P Biotech ETF is publicly traded.
What exchange does State Street SPDR S&P Biotech ETF trade on?
State Street SPDR S&P Biotech ETF trades on the New York Stock Exchange
What is the ticker symbol for State Street SPDR S&P Biotech ETF?
The ticker symbol for State Street SPDR S&P Biotech ETF is XBI on the New York Stock Exchange
What is the current price of State Street SPDR S&P Biotech ETF?
The current price of State Street SPDR S&P Biotech ETF is 144.12
When was State Street SPDR S&P Biotech ETF last traded?
The last trade of State Street SPDR S&P Biotech ETF was at 11/19/26 08:00 PM ET
What is the market capitalization of State Street SPDR S&P Biotech ETF?
The market capitalization of State Street SPDR S&P Biotech ETF is 78.04M
How many shares of State Street SPDR S&P Biotech ETF are outstanding?
State Street SPDR S&P Biotech ETF has 78M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
>